Cytosorbents (CTSO) Asset Utilization Ratio (2012 - 2026)
Cytosorbents' (CTSO) quarterly Asset Utilization Ratio came in at 0.88 in Q1 2026, up 21.94% YoY from 0.72 in Q1 2025, and up 6.51% on a QoQ basis from 0.82 in Q4 2025.
Cytosorbents (CTSO) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 14 years of Asset Utilization Ratio data on file, last reported at 0.88 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 21.94% year-over-year to 0.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.88 (up 21.94% YoY) and the FY2025 annual result came in at 0.81, up 14.1% from the prior year.
- Asset Utilization Ratio climbed to 0.88 in Q1 2026, from 0.82 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.88 in Q1 2026 to a low of 0.48 in Q1 2022.
- A 5-year average of 0.68 and a median of 0.72 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 37.11% — and 2024, when it declined 6.42%.
- Tracing CTSO's Asset Utilization Ratio over 5 years: stood at 0.55 in 2022, then jumped by 30.81% to 0.72 in 2023, then advanced by 3.44% to 0.75 in 2024, then climbed by 10.19% to 0.82 in 2025, then rose by 6.51% to 0.88 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.88 (Q1 2026), 0.82 (Q4 2025), and 0.79 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 0.56 |
| 10 | Cytosorbents | 21.57 Mn | 17.16 Mn | 7.05 Mn | 0.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.95 |
| Mar 31, 2026 | 0.88 |
| Dec 31, 2025 | 0.82 |
| Sep 30, 2025 | 0.79 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.72 |
| Dec 31, 2024 | 0.75 |
| Sep 30, 2024 | 0.69 |
| Jun 30, 2024 | 0.70 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.72 |
| Sep 30, 2023 | 0.74 |
| Jun 30, 2023 | 0.66 |
| Mar 31, 2023 | 0.59 |
| Dec 31, 2022 | 0.55 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.49 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.46 |